LEMAITRE VASCULAR, INC. (LMAT) Gross margin 2016–2025
LEMAITRE VASCULAR, INC. (LMAT) gross margin by fiscal year — reported gross profit divided by reported revenue.
71.5%FY2025 · since FY2016: 70.6% → 71.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 71.5% | +2.9 pp |
| FY2024 | 68.6% | +3.0 pp |
| FY2023 | 65.7% | +0.8 pp |
| FY2022 | 64.9% | -0.8 pp |
| FY2021 | 65.7% | +0.2 pp |
| FY2020 | 65.4% | -2.7 pp |
| FY2019 | 68.1% | -1.9 pp |
| FY2018 | 70.0% | -0.1 pp |
| FY2017 | 70.1% | -0.5 pp |
| FY2016 | 70.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LMAT financial trends
LMAT RevenueLMAT Net incomeLMAT Net marginLMAT Gross profitLMAT Operating incomeLMAT Operating marginLMAT Operating cash flowLMAT Free cash flowLMAT Capital expendituresLMAT Return on equityLMAT Stock buybacksLMAT Dividends paidLMAT Total assetsLMAT Total liabilitiesLMAT Shareholders’ equityLMAT overview →